WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced that seven abstracts highlighting the company’s growing pipeline of novel kinase inhibitors have been selected for presentation at the American Association for Cancer Research Annual Meeting 2015, which is being held April 18-22 in Philadelphia.
Help employers find you! Check out all the jobs and post your resume.
